Superior Planning, LLC’s Coya Therapeutics COYA Stock Holding History

Superior Planning, LLC’s Portfolio COYA Stock Details COYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.58K	Buy	+315	New	+$1.5K	﹤0.01%	1629

Other funds holding COYA

ACM

AIGH Capital Management Baltimore, Maryland $992M AUM 516.32% 1-Year Est. Return

CM Management Gulf Breeze, Florida $149M AUM 35.54% 1-Year Est. Return

Private Management Group Irvine, California $3.63B AUM 11.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Long Corridor Asset Management Hong Kong $329M AUM 0.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Jane Street New York $1.19T AUM 51.51% 1-Year Est. Return

Superior Planning, LLC's COYA Position: Q3 2026 in Review

Superior Planning, LLC opened a new position in Coya Therapeutics (COYA) in Q3 2026: 315 shares worth $1.58K. The stake represents ﹤0.01% of the portfolio and ranks #1629 among its holdings.

26 funds tracked by Wall St. Rank hold COYA as of Q3 2026.

Superior Planning, LLC held 315 shares of Coya Therapeutics worth $1.58K as of Q3 2026.
Coya Therapeutics was a new Superior Planning, LLC position in Q3 2026.
Coya Therapeutics made up ﹤0.01% of Superior Planning, LLC's portfolio in Q3 2026, its #1629 holding.
26 funds tracked by Wall St. Rank held Coya Therapeutics as of Q3 2026.

Based on Superior Planning, LLC's 13F filing for Q3 2026, filed 12 Nov 2026.